1.74
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IOVA?
Forum
Prognose
Aktiensplit
Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent
The Gross Law Firm Notifies Shareholders of Iovance Biotherapeutics, Inc. (IOVA) of a Class ... - Bluefield Daily Telegraph
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - FinancialContent
Wealth Enhancement Advisory Services LLC Lowers Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal PressureHagens Berman - ACCESS Newswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK - Bluefield Daily Telegraph
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire
Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart - MarketScreener
ROSEN, A LEADING LAW FIRM, Encourages Iovance - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was - GlobeNewswire
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky Before July 14, 2025 to Join Class Action - ACCESS Newswire
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class ActionIOVA - PR Newswire
Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance ... - Eagle-Tribune
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Iovance Biotherapeutics, Inc.(IOVA) Shareholders - GlobeNewswire Inc.
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline - ACCESS Newswire
Iovance Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationIOVA - The Victoria Advocate
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider
Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating - Seeking Alpha
IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA) - GlobeNewswire
iovance cfo resigns to pursue new opportunities By Investing.com - Investing.com India
iovance cfo resigns to pursue new opportunities - Investing.com
Iovance Biotherapeutics IncJean-Marc Bellemin To Resign As CFO - marketscreener.com
Iovance Biotherapeutics’ SWOT analysis: TIL therapy stock faces challenges amid promise - Investing.com India
Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
Shareholders of Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Iovance Biotherapeutics, Inc. (IOVA) should contact Levi & ... - Bluefield Daily Telegraph
Investors who lost money on Iovance Biotherapeutics, Inc. - GlobeNewswire
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - marketscreener.com
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire
IOVA CLASS ACTION: Invest in Iovance Biotherapeutics, Inc.? - GlobeNewswire
Levi & Korsinsky Urges Iovance Biotherapeutics, Inc. (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025 - ACCESS Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - GlobeNewswire
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor LawsuitHagens Berman - ACCESS Newswire
Iovance Biotherapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross ... - Bluefield Daily Telegraph
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Victoria Advocate
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire
Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA) – Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS ... - Bluefield Daily Telegraph
Transcript : Iovance Biotherapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 01 - marketscreener.com
IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, - GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ... - Bluefield Daily Telegraph
Iovance Biotherapeutics, Inc. (IOVA) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action LawsuitContact Kaplan Fox - FinancialContent
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):